OncoCyte Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	11.13	21.69	34.65	8.84	22.07	8.03	7.6	10.25	8	0.26
Short-Term Investments	0	0.43	0.9	0.68	0.38	0.43	0.76	2.24	2.54	3.28
Cash & Cash Equivalents	11.13	22.13	35.55	9.52	22.45	8.46	8.36	12.49	10.54	3.54
Cash Growth	-49.69%	-37.76%	273.52%	-57.61%	165.32%	1.22%	-33.05%	18.50%	197.91%	-
Receivables	0.48	2.01	1.44	0.2	0	0	0	0	0	0
Other Current Assets	-0.92	1.4	2.15	-0.5	0.51	0.18	0.17	0.21	0.39	0.11
Total Current Assets	10.7	25.54	39.14	9.23	22.96	8.64	8.53	12.7	10.93	3.65
Property, Plant & Equipment	5.44	10.85	8.37	6.52	3.73	0.61	0.82	0.69	0.58	0.12
Long-Term Investments	0	0	0	13.42	10.96	0	0	0	0	0
Goodwill and Intangibles	56.6	61.63	80.41	24.2	0	0	0.75	0.99	1.23	1.47
Other Long-Term Assets	2.16	2.07	31.65	2.06	2.21	0.26	0.12	0.08	0	0
Total Long-Term Assets	64.19	74.56	120.42	46.19	16.9	0.88	1.69	1.75	1.81	1.59
Total Assets	74.89	100.09	159.56	55.42	39.86	9.52	10.22	14.45	12.73	5.24
Accounts Payable	0.95	1.25	1.81	0.43	0.48	2.27	2.27	3.28	1.13	6.03
Current Debt	0.67	0.82	2.13	2.81	1.36	1.19	1.14	0.2	0	0
Other Current Liabilities	5.58	10.04	10.18	5.75	2.61	2.11	1.04	0.8	1.18	0.28
Total Current Liabilities	7.19	12.11	14.12	9	4.44	5.56	4.45	4.28	2.31	6.32
Long-Term Debt	2.2	2.73	3.55	5.82	4.58	0.53	1.36	0.31	0	0
Other Long-Term Liabilities	39.9	45.66	76.68	7.12	0	0	0	0	0	0
Total Long-Term Liabilities	42.1	48.39	80.23	12.94	4.58	0.53	1.36	0.31	0	0
Total Liabilities	49.3	60.5	94.35	21.94	9.02	6.1	5.81	4.59	2.31	6.32
Total Debt	2.87	3.54	5.68	8.63	5.94	1.72	2.5	0.51	0	0
Debt Growth	-19.05%	-37.57%	-34.23%	45.42%	245.32%	-31.16%	387.70%	-	-	-
Retained Earnings	-289.88	-260.68	-187.77	-123.68	-93.75	-71.32	-54.68	-35.3	-24.13	-15.4
Comprehensive Income	0.05	0.04	0.04	0	0	0	-0.89	-0.65	-0.35	-0.82
Shareholders' Equity	20.47	34.29	65.22	33.48	30.84	3.42	4.4	9.86	10.42	-1.07
Net Cash / Debt	8.26	18.58	29.88	0.89	16.52	6.74	5.86	11.97	10.54	3.54
Net Cash / Debt Growth	-55.53%	-37.80%	3271.90%	-94.64%	144.92%	15.01%	-51.04%	13.64%	197.91%	-
Net Cash Per Share	1.08	3.35	6.72	0.27	6.44	3.56	3.88	9.03	10.03	3.89
Working Capital	3.5	13.43	25.02	0.23	18.52	3.08	4.07	8.42	8.61	-2.66
Book Value Per Share	2.67	6.19	14.67	10.23	12.02	1.81	2.92	7.43	9.92	-1.18

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).